Arcturus Therapeutics Holdings (ARCT) SEC Filings: History & Chart

Arcturus Therapeutics Holdings Inc.(ARCT)

Biotechnology · San Diego, CA

$14.77+0.11 (+0.75%)

Delayed quote: Oct 6, 2026, 9:34 AM EDT

About Arcturus Therapeutics Holdings Inc.

Arcturus Therapeutics Holdings Inc. is a biotechnology company focused on RNA-based medicines, developing a pipeline of vaccines for infectious diseases alongside treatments for rare liver and respiratory conditions across the United States. Its notable development programs encompass LUNAR-OTC, designed for ornithine transcarbamylase (OTC) deficiency, and LUNAR-CF, targeting cystic fibrosis lung disease caused by specific CFTR gene mutations. The company also advances vaccine initiatives such as LUNAR-COV19 and LUNAR-FLU. Arcturus has cultivated a range of strategic collaborations, including partnerships with Vinbiocare Biotechnology Joint Stock Company for manufacturing COVID-19 vaccines; Janssen Pharmaceuticals, Inc., to create nucleic acid-based therapies for hepatitis B virus; Ultragenyx Pharmaceutical, Inc., for developing mRNA therapeutics aimed at rare disease targets; CureVac AG, to progress mRNA therapeutic and vaccine candidates across various indications; the Singapore Economic Development Board and Duke-NUS Medical School, specifically for the LUNAR-COV19 vaccine; and Millennium Pharmaceuticals, Inc., focused on discovering siRNA medicines for non-alcoholic steatohepatitis (NASH). Founded in 2013, Arcturus Therapeutics maintains its corporate headquarters in San Diego, California.

San Diego, CA

109 employees

arcturusrx.com

Healthcare / Biotechnology

Sector: Healthcare
Industry: Biotechnology
CEO: Joseph E. Payne

View full financials

Form	Filing Date	Accepted	Document
8-K	Sep 23, 2026	Sep 23, 2026	View filing
8-K	Aug 25, 2026	Aug 25, 2026	View filing
10-Q	Aug 6, 2026	Aug 6, 2026	View filing
8-K	Aug 6, 2026	Aug 6, 2026	View filing
8-K	Jul 2, 2026	Jul 2, 2026	View filing
4	Jun 15, 2026	Jun 15, 2026	View filing
4	Jun 15, 2026	Jun 15, 2026	View filing
4	Jun 15, 2026	Jun 15, 2026	View filing
4	Jun 15, 2026	Jun 15, 2026	View filing
4	Jun 15, 2026	Jun 15, 2026	View filing
4	Jun 15, 2026	Jun 15, 2026	View filing
4	Jun 15, 2026	Jun 15, 2026	View filing
8-K	Jun 5, 2026	Jun 5, 2026	View filing
4	May 7, 2026	May 7, 2026	View filing
3	May 7, 2026	May 7, 2026	View filing
10-Q	May 7, 2026	May 7, 2026	View filing
8-K	May 7, 2026	May 7, 2026	View filing
SC 13G/A	May 7, 2026	May 7, 2026	View filing
DEF 14A	Apr 24, 2026	Apr 24, 2026	View filing
SC 13G/A	Mar 26, 2026	Mar 26, 2026	View filing
10-K	Mar 3, 2026	Mar 3, 2026	View filing
8-K	Mar 3, 2026	Mar 3, 2026	View filing
SC 13G/A	Feb 17, 2026	Feb 17, 2026	View filing
SC 13G/A	Feb 3, 2026	Feb 3, 2026	View filing
SC 13G/A	Jan 8, 2026	Jan 8, 2026	View filing
S-3	Dec 30, 2025	Dec 30, 2025	View filing
4	Dec 19, 2025	Dec 19, 2025	View filing
4	Dec 19, 2025	Dec 19, 2025	View filing
4	Dec 19, 2025	Dec 19, 2025	View filing
4	Dec 19, 2025	Dec 19, 2025	View filing

SEC Filings

Recent Filings